These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 31617773

  • 1. Prognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancer.
    Jaskulski S, Jung AY, Huebner M, Poschet G, Hell R, Hüsing A, Gonzalez-Maldonado S, Behrens S, Obi N, Becher H, Chang-Claude J.
    Nutr Cancer; 2020; 72(7):1155-1169. PubMed ID: 31617773
    [Abstract] [Full Text] [Related]

  • 2. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
    Kyrø C, Hansen L, Frederiksen K, Nørskov NP, Bach Knudsen KE, Eriksen AK, Holm M, Tjønneland A, Olsen A.
    Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
    Jaskulski S, Jung AY, Behrens S, Johnson T, Kaaks R, Thöne K, Flesch-Janys D, Sookthai D, Chang-Claude J.
    Int J Cancer; 2018 Dec 01; 143(11):2698-2708. PubMed ID: 29974464
    [Abstract] [Full Text] [Related]

  • 5. Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.
    Jaskulski S, Jung AY, Rudolph A, Johnson T, Thöne K, Herpel E, Sinn P, Chang-Claude J.
    Mol Nutr Food Res; 2017 Nov 01; 61(11):. PubMed ID: 28734033
    [Abstract] [Full Text] [Related]

  • 6. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
    Piller R, Chang-Claude J, Linseisen J.
    Eur J Cancer Prev; 2006 Jun 01; 15(3):225-32. PubMed ID: 16679865
    [Abstract] [Full Text] [Related]

  • 7. Plasma phytoestrogens and subsequent breast cancer risk.
    Verheus M, van Gils CH, Keinan-Boker L, Grace PB, Bingham SA, Peeters PH.
    J Clin Oncol; 2007 Feb 20; 25(6):648-55. PubMed ID: 17200150
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period.
    Zeleniuch-Jacquotte A, Adlercreutz H, Akhmedkhanov A, Toniolo P.
    Cancer Epidemiol Biomarkers Prev; 1998 Oct 20; 7(10):885-9. PubMed ID: 9796633
    [Abstract] [Full Text] [Related]

  • 10. Urinary phytoestrogens and postmenopausal breast cancer risk.
    den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH.
    Cancer Epidemiol Biomarkers Prev; 2001 Mar 20; 10(3):223-8. PubMed ID: 11303591
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in men.
    Low YL, Taylor JI, Grace PB, Dowsett M, Folkerd E, Doody D, Dunning AM, Scollen S, Mulligan AA, Welch AA, Luben RN, Khaw KT, Day NE, Wareham NJ, Bingham SA.
    J Nutr; 2005 Nov 20; 135(11):2680-6. PubMed ID: 16251630
    [Abstract] [Full Text] [Related]

  • 13. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
    Zaineddin AK, Vrieling A, Buck K, Becker S, Linseisen J, Flesch-Janys D, Kaaks R, Chang-Claude J.
    Int J Cancer; 2012 Mar 15; 130(6):1401-10. PubMed ID: 21544804
    [Abstract] [Full Text] [Related]

  • 14. Dietary phytoestrogens and biomarkers of their intake in relation to cancer survival and recurrence: a comprehensive systematic review with meta-analysis.
    Micek A, Godos J, Brzostek T, Gniadek A, Favari C, Mena P, Libra M, Del Rio D, Galvano F, Grosso G.
    Nutr Rev; 2021 Jan 01; 79(1):42-65. PubMed ID: 32632445
    [Abstract] [Full Text] [Related]

  • 15. CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.
    Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J.
    J Nutr; 2006 Jun 01; 136(6):1596-603. PubMed ID: 16702327
    [Abstract] [Full Text] [Related]

  • 16. Circulating enterolactone and risk of endometrial cancer.
    Zeleniuch-Jacquotte A, Lundin E, Micheli A, Koenig KL, Lenner P, Muti P, Shore RE, Johansson I, Krogh V, Lukanova A, Stattin P, Afanasyeva Y, Rinaldi S, Arslan AA, Kaaks R, Berrino F, Hallmans G, Toniolo P, Adlercreutz H.
    Int J Cancer; 2006 Nov 15; 119(10):2376-81. PubMed ID: 16929490
    [Abstract] [Full Text] [Related]

  • 17. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
    Guglielmini P, Rubagotti A, Boccardo F.
    Breast Cancer Res Treat; 2012 Apr 15; 132(2):661-8. PubMed ID: 22094938
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of enterolactone and percentage mammographic density among postmenopausal women.
    Stuedal A, Gram IT, Bremnes Y, Adlercreutz H, Veierød MB, Ursin G.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep 15; 14(9):2154-9. PubMed ID: 16172225
    [Abstract] [Full Text] [Related]

  • 19. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.
    Xie J, Tworoger SS, Franke AA, Terry KL, Rice MS, Rosner BA, Willett WC, Hankinson SE, Eliassen AH.
    Breast Cancer Res Treat; 2013 Jun 15; 139(3):801-9. PubMed ID: 23760859
    [Abstract] [Full Text] [Related]

  • 20. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
    Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H.
    Cancer Epidemiol Biomarkers Prev; 2001 Apr 15; 10(4):339-44. PubMed ID: 11319174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.